A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 5, 2005, Pages 1488-1493

  Hille, Andrea ^a   Schmidberger, Heinz ^a   Hermann, Robert M ^a   Christiansen, Hans ^a   Saile, Bernhard ^a   Pradier, Olivier ^a   Hess, Clemens F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acute proctitis; Misoprostol; Prostate cancer; Radiotherapy

Indexed keywords

PATIENT MONITORING; RADIOTHERAPY; TOXICITY; TUMORS;

ACUTE PROCTITIS; MISOPROSTOL; PELVIC RADIATION; PROSTATE CANCER;

ONCOLOGY;

MISOPROSTOL; PLACEBO;

AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; TOXICITY;

ACUTE DISEASE; AGED; ANTI-ULCER AGENTS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; HUMANS; MALE; MISOPROSTOL; PROCTITIS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RECTUM; STATISTICS, NONPARAMETRIC; SUPPOSITORIES;

EID: 27744462841     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.05.063     Document Type: Article

References (54)

1. P.C. Koper, J.C. Stroom, W.L. van Putten Acute morbidity reduction using 3DCRT for prostate carcinoma A randomized study Int J Radiat Oncol Biol Phys 43 1997 727 734
2. J.M. Michalski, J.A. Purdy, K. Winter Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 Int J Radiat Oncol Biol Phys 46 2000 391 402
3. P.C. O'Brien, C.I. Franklin, K.B. Dear A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis Radiother Oncol 45 1997 117 123
4. M.R. Storey, A. Pollack, G. Zagars Complications from radiotherapy dose escalation in prostate cancer Preliminary results of a randomized trial Int J Radiat Oncol Biol Phys 48 2000 635 642
5. T. Girinsky, A. Rey, B. Roche Overall treatment time in advanced cervical carcinomas A critical parameter in treatment outcome Int J Radiat Oncol Biol Phys 27 1993 1051 1056
6. J.A. Martenson Jr, G. Hyland, C.G. Moertel Olsalazine is contraindicated during pelvic radiation therapy Results of a double-blind, randomized clinical trial Int J Radiat Oncol Biol Phys 35 1996 299 303
7. C.L. Shrader-Bogen, J.L. Kjellberg, C.P. McPherson Quality of life and treatment outcomes Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy Cancer 79 1997 1977 1986
8. A. Widmark, P. Fransson, B. Tavelin Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population Cancer 74 1994 2520 2532
9. T.E. Schultheiss, W.R. Lee, M.A. Hunt Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
10. E. Weiss, P. Hirnle, H. Arnold-Bofinger Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma Stage I and II Radiother Oncol 53 1999 37 44
11. F.B. Zimmermann, H.J. Feldmann Radiation proctitis Clinical and pathological manifestations, therapy, and prophylaxis of acute and late injurious effects of radiation on the rectal mucosa Strahlenther Onkol 174 Suppl. 3 1998 85 89
12. J. Classen, C. Belka, F. Paulsen Radiation-induced gastrointestinal toxicity Pathophysiology, approaches to treatment, and prophylaxis Strahlenther Onkol 174 Suppl. 3 1998 82 84
13. A.S. Denton, H.J. Andreyev, A. Forbes Systematic review for non-surgical interventions for the management of late radiation proctitis Br J Cancer 87 2002 134 143
14. F. Paulsen, W. Hoffmann, R.D. Kortmann Acute gastrointestinal side effects of radiotherapy What is certain in the treatment? Strahlenther Onkol 172 1996 53 63
15. E.B. Rubenstein, D.E. Peterson, M. Schubert Mucositis Study Section of the Multinational Association for Supportive Care in Cancer International Society for Oral Oncology Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100 Suppl. 9 2004 2026 2046
16. A.M. Khan, J.W. Birk, J.C. Anderson A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients Am J Gastroenterol 95 2000 1961 1966
17. L.H. Sobin, C. Wittekind TNM classification of malignant tumours 5th ed. 1997 Wiley-Liss New York
18. A. Trotti, R. Byhardt, J. Stetz Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
19. International Commission on Radiation Units and Measurements ICRU report 50 Prescribing, recording, and reporting photon beam therapy 1993 International Commission on Radiation Units and Measurements Washington, DC
20. S. Wachter, N. Gerstner, D. Dorner The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 52 2002 91 100
21. N. Gerstner, S. Wachter, D. Dorner Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma Strahlenther Onkol 175 1999 232 238
22. A.V. D'Amico, J. Manola, M. Loffredo A practical method to achieve prostate gland immobilization and target verification for daily treatment Int J Radiat Oncol Biol Phys 51 2001 1431 1436
23. S.H. Herbert, W.J. Curran Jr, L.J. Solin Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation Int J Radiat Oncol Biol Phys 20 1991 835 842
24. O. Koelbl, S. Richter, M. Flentje Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation A prospective study using a 3D planning system and a radiobiological model Int J Radiat Oncol Biol Phys 45 1999 1193 1198
25. T.G. Shanahan, M.P. Mehta, K.L. Bertelrud Minimization of small bowel volume within treatment fields utilizing customized "belly boards." Int J Radiat Oncol Biol Phys 19 1990 469 476
26. G. Sanguineti, P. Franzone, M. Marcenaro Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma A randomized study Strahlenther Onkol 179 2003 464 470
27. R. Henriksson, L. Franzen, B. Littbrand Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer J Clin Oncol 10 1992 969 975
28. R. Henriksson, L. Franzen, B. Littbrand Prevention and therapy of radiation-induced bowel discomfort Scand J Gastroenterol 191 Suppl 1992 7 11
29. A. Kneebone, H. Mameghan, T. Bolin The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy A double-blind, randomized trial Int J Radiat Oncol Biol Phys 51 2001 628 635
30. M.M. Kligerman, T. Liu, Y. Liu Interim analysis of a randomized trial of radiation therapy of rectal cancer with/without WR-2721 Int J Radiat Oncol Biol Phys 22 1992 799 802
31. M.I. Koukourakis, G. Kyrias, S. Kakolyris Subcutaneous administration of amifostine during fractionated radiotherapy A randomized phase II study J Clin Oncol 18 2000 2226 2233
32. T. Liu, Y. Liu, S. He Use of radiation with or without WR-2721 in advanced rectal cancer Cancer 69 1992 2820 2825
33. J. Kouvaris, V. Kouloulias, E. Malas Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors A phase II randomized study using various toxicity scales and rectosigmoidoscopy Strahlenther Onkol 179 2003 167 174
34. J. Kouvaris, V. Kouloulias, J. Kokakis Cytoprotective effect of amifostine in radiation-induced acute mucositis - A retrospective analysis Onkologie 25 2002 364 369
35. R. Myerson, I. Zobeiri, E. Birnbaum Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma Semin Oncol 29 6 Suppl. 19 2002 29 33
36. G.S. Montana, M.S. Anscher, C.M. Mansbach II Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis A phase I/II trial Cancer 69 1992 2826 2830
37. 1 analog, misoprostol A placebo controlled double blind clinical trial Adv Exp Med Biol 400B 1997 811 818
38. D.Y. Graham, N.M. Agrawal, S.H. Roth Prevention of NSAID-induced gastric ulcer with misoprostol Multicentre, double-blind, placebo-controlled trial Lancet 3 1988 1277 1280
39. D.Y. Graham, R.H. White, L.W. Moreland Misoprostol Study Group Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs Ann Intern Med 119 1993 257 262
40. W.R. Hanson, K.A. Houseman, P.W. Collins Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade Pharmacol Ther 39 1988 347 356
41. 2 Prostaglandins 26 1983 745 759
42. 2 treatment on the rat gastrointestinal mucosa Gastroenterology 85 1983 1003 1010
43. J.P. Delaney, M.E. Bonsack, I. Felemovicius Misoprostol in the intestinal lumen protects against radiation injury of the mucosa of the small bowel Radiat Res 137 1994 405 409
44. 1 analogue, given alone or with WR-2721, is stereospecific Prostaglandins Leukot Essent Fatty Acids 32 1988 101 105
45. 2 induces radioprotection in murine intestinal and hematopoietic stem cells Radiat Res 103 1985 196 203
46. 2 increases survival of murine intestinal stem cells when given before photon radiation Radiat Res 96 1983 393 398
47. W.R. Hanson, K. DeLaurentiis Comparison of in vivo murine intestinal radiation protection by E-prostaglandins Prostaglandins 33 Suppl 1987 93 104
48. L.R. Empey, J.D. Papp, L.D. Jewell Mucosal protective effects of vitamin E and misoprostol during acute radiation-induced enteritis in rats Dig Dis Sci 37 1992 205 214
49. 2, on intestinal transport and morphology following abdominal irradiation in the rat Can J Physiol Pharmacol 67 1989 1351 1356
50. 2, on intestinal brush border membrane lipid composition following abdominal irradiation in the rat Clin Invest Med 12 1989 350 356
51. D.P. Dearnaley, V.S. Khoo, A.R. Norman Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer A randomised trial Lancet 353 1999 267 272
52. A. Pollack, G.K. Zagars, G. Starkschall Conventional vs. conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity Int J Radiat Oncol Biol Phys 34 1996 555 564
53. P.C. Koper, J.C. Stroom, W.L. van Putten Acute morbidity reduction using 3DCRT for prostate carcinoma A randomized study Int J Radiat Oncol Biol Phys 43 1999 727 734
54. P.C. Koper, P. Jansen, W. van Putten Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer Observations of a randomized trial Radiother Oncol 73 2004 1 9